Skip to main content
logo
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.5587
+0.0492 (9.66%)
Nov 9, 2026, 3:02 PM EST - Market open

Citius Oncology Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22
Market Capitalization
591709996-
Market Cap Growth
-54.06%71.05%2.93%--
Enterprise Value
53173---
Last Close Price
0.512.031.3910.77-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22
Forward PE
-89.00---
PB Ratio
1.333.782.153.77-
P/TBV Ratio
1.493.782.153.77-
P/OCF Ratio
--784.41--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22
Debt / Equity Ratio
0.250.090.08--
Net Debt / Equity Ratio
-0.160.000.08--
Quick Ratio
0.290.080--
Current Ratio
0.730.560.340.370.46
Return on Equity (ROE)
-126.58%-54.42%-59.01%-41.09%-
Return on Assets (ROA)
-29.12%-15.87%-19.47%-16.76%-
Return on Capital Employed (ROCE)
-89.10%-45.70%-39.80%-45.40%-26.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '25 Sep '24 Sep '23 Sep '22
Earnings Yield
-88.26%-14.61%-21.34%-13.19%-
Buyback Yield / Dilution
-31.40%-7.66%-0.82%-100.00%-
SEC Filings: 10-K · 10-Q